nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethinyl Estradiol—breast cancer—Dexamethasone—multiple sclerosis	0.237	0.5	CpDpCtD
Ethinyl Estradiol—breast cancer—Betamethasone—multiple sclerosis	0.237	0.5	CpDpCtD
Ethinyl Estradiol—Danazol—Prednisone—multiple sclerosis	0.0678	0.415	CrCrCtD
Ethinyl Estradiol—Methyltestosterone—Prednisone—multiple sclerosis	0.0484	0.296	CrCrCtD
Ethinyl Estradiol—Methyltestosterone—Prednisolone—multiple sclerosis	0.0472	0.289	CrCrCtD
Ethinyl Estradiol—AOX1—Methotrexate—multiple sclerosis	0.0458	0.184	CbGbCtD
Ethinyl Estradiol—ABCB11—Dexamethasone—multiple sclerosis	0.0327	0.132	CbGbCtD
Ethinyl Estradiol—ABCC2—Dexamethasone—multiple sclerosis	0.0172	0.0692	CbGbCtD
Ethinyl Estradiol—ABCB1—Methylprednisolone—multiple sclerosis	0.0148	0.0596	CbGbCtD
Ethinyl Estradiol—ABCC2—Methotrexate—multiple sclerosis	0.0138	0.0556	CbGbCtD
Ethinyl Estradiol—CYP3A4—Fingolimod—multiple sclerosis	0.0138	0.0554	CbGbCtD
Ethinyl Estradiol—CYP2B6—Dexamethasone—multiple sclerosis	0.0109	0.044	CbGbCtD
Ethinyl Estradiol—ABCB1—Mitoxantrone—multiple sclerosis	0.0108	0.0435	CbGbCtD
Ethinyl Estradiol—ABCB1—Betamethasone—multiple sclerosis	0.00965	0.0388	CbGbCtD
Ethinyl Estradiol—ABCB1—Prednisolone—multiple sclerosis	0.00952	0.0382	CbGbCtD
Ethinyl Estradiol—ABCB1—Prednisone—multiple sclerosis	0.00899	0.0361	CbGbCtD
Ethinyl Estradiol—CYP3A4—Methylprednisolone—multiple sclerosis	0.00889	0.0357	CbGbCtD
Ethinyl Estradiol—CYP2C8—Dexamethasone—multiple sclerosis	0.00829	0.0333	CbGbCtD
Ethinyl Estradiol—CYP3A4—Triamcinolone—multiple sclerosis	0.00674	0.0271	CbGbCtD
Ethinyl Estradiol—CYP3A4—Mitoxantrone—multiple sclerosis	0.00649	0.0261	CbGbCtD
Ethinyl Estradiol—CYP3A4—Betamethasone—multiple sclerosis	0.00578	0.0232	CbGbCtD
Ethinyl Estradiol—CYP3A4—Prednisolone—multiple sclerosis	0.00571	0.0229	CbGbCtD
Ethinyl Estradiol—ABCB1—Dexamethasone—multiple sclerosis	0.00561	0.0225	CbGbCtD
Ethinyl Estradiol—CYP3A4—Prednisone—multiple sclerosis	0.00539	0.0216	CbGbCtD
Ethinyl Estradiol—ABCB1—Methotrexate—multiple sclerosis	0.00451	0.0181	CbGbCtD
Ethinyl Estradiol—CYP3A4—Dexamethasone—multiple sclerosis	0.00336	0.0135	CbGbCtD
Ethinyl Estradiol—Norelgestromin—PGR—multiple sclerosis	0.000571	0.176	CrCbGaD
Ethinyl Estradiol—Desogestrel—PGR—multiple sclerosis	0.000549	0.169	CrCbGaD
Ethinyl Estradiol—Danazol—CCL2—multiple sclerosis	0.00047	0.145	CrCbGaD
Ethinyl Estradiol—Etonogestrel—PGR—multiple sclerosis	0.000445	0.137	CrCbGaD
Ethinyl Estradiol—Levonorgestrel—PGR—multiple sclerosis	0.000315	0.0968	CrCbGaD
Ethinyl Estradiol—Danazol—PGR—multiple sclerosis	0.000286	0.0882	CrCbGaD
Ethinyl Estradiol—Norethindrone—PGR—multiple sclerosis	0.000255	0.0785	CrCbGaD
Ethinyl Estradiol—Discomfort—Mitoxantrone—multiple sclerosis	0.000119	0.00156	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Methylprednisolone—multiple sclerosis	0.000118	0.00155	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Azathioprine—multiple sclerosis	0.000118	0.00154	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000117	0.00153	CcSEcCtD
Ethinyl Estradiol—Dizziness—Cladribine—multiple sclerosis	0.000117	0.00152	CcSEcCtD
Ethinyl Estradiol—Oedema—Mitoxantrone—multiple sclerosis	0.000116	0.00152	CcSEcCtD
Ethinyl Estradiol—Infection—Mitoxantrone—multiple sclerosis	0.000115	0.00151	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Methylprednisolone—multiple sclerosis	0.000115	0.0015	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Azathioprine—multiple sclerosis	0.000113	0.00148	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Azathioprine—multiple sclerosis	0.000113	0.00148	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Mitoxantrone—multiple sclerosis	0.000113	0.00147	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Dexamethasone—multiple sclerosis	0.000112	0.00147	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Betamethasone—multiple sclerosis	0.000112	0.00147	CcSEcCtD
Ethinyl Estradiol—Irritability—Methotrexate—multiple sclerosis	0.000112	0.00147	CcSEcCtD
Ethinyl Estradiol—Vomiting—Cladribine—multiple sclerosis	0.000112	0.00147	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Betamethasone—multiple sclerosis	0.000112	0.00146	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Dexamethasone—multiple sclerosis	0.000112	0.00146	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Methylprednisolone—multiple sclerosis	0.000111	0.00146	CcSEcCtD
Ethinyl Estradiol—Mood swings—Methotrexate—multiple sclerosis	0.000111	0.00145	CcSEcCtD
Ethinyl Estradiol—Rash—Cladribine—multiple sclerosis	0.000111	0.00145	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Cladribine—multiple sclerosis	0.000111	0.00145	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000111	0.00145	CcSEcCtD
Ethinyl Estradiol—Weight increased—Prednisone—multiple sclerosis	0.000111	0.00145	CcSEcCtD
Ethinyl Estradiol—Headache—Cladribine—multiple sclerosis	0.00011	0.00144	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Prednisone—multiple sclerosis	0.00011	0.00144	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000108	0.00141	CcSEcCtD
Ethinyl Estradiol—Depression—Prednisone—multiple sclerosis	0.000108	0.00141	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Betamethasone—multiple sclerosis	0.000108	0.00141	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Dexamethasone—multiple sclerosis	0.000108	0.00141	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Methylprednisolone—multiple sclerosis	0.000108	0.00141	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Methylprednisolone—multiple sclerosis	0.000107	0.0014	CcSEcCtD
Ethinyl Estradiol—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000107	0.0014	CcSEcCtD
Ethinyl Estradiol—Angioedema—Prednisolone—multiple sclerosis	0.000106	0.00139	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Prednisone—multiple sclerosis	0.000106	0.00139	CcSEcCtD
Ethinyl Estradiol—Myocardial infarction—Prednisone—multiple sclerosis	0.000106	0.00139	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Methotrexate—multiple sclerosis	0.000106	0.00139	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Azathioprine—multiple sclerosis	0.000106	0.00138	CcSEcCtD
Ethinyl Estradiol—Malaise—Prednisolone—multiple sclerosis	0.000105	0.00137	CcSEcCtD
Ethinyl Estradiol—Nausea—Cladribine—multiple sclerosis	0.000105	0.00137	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Dexamethasone—multiple sclerosis	0.000104	0.00136	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Betamethasone—multiple sclerosis	0.000104	0.00136	CcSEcCtD
Ethinyl Estradiol—Estropipate—ALB—multiple sclerosis	0.000104	0.0321	CrCbGaD
Ethinyl Estradiol—Back pain—Triamcinolone—multiple sclerosis	0.000104	0.00135	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Betamethasone—multiple sclerosis	0.000101	0.00132	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Dexamethasone—multiple sclerosis	0.000101	0.00132	CcSEcCtD
Ethinyl Estradiol—Fatigue—Mitoxantrone—multiple sclerosis	9.99e-05	0.00131	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Triamcinolone—multiple sclerosis	9.94e-05	0.0013	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Methylprednisolone—multiple sclerosis	9.91e-05	0.0013	CcSEcCtD
Ethinyl Estradiol—Constipation—Mitoxantrone—multiple sclerosis	9.91e-05	0.0013	CcSEcCtD
Ethinyl Estradiol—Alopecia—Dexamethasone—multiple sclerosis	9.86e-05	0.00129	CcSEcCtD
Ethinyl Estradiol—Alopecia—Betamethasone—multiple sclerosis	9.86e-05	0.00129	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Azathioprine—multiple sclerosis	9.8e-05	0.00128	CcSEcCtD
Ethinyl Estradiol—Discomfort—Prednisolone—multiple sclerosis	9.8e-05	0.00128	CcSEcCtD
Ethinyl Estradiol—Angioedema—Triamcinolone—multiple sclerosis	9.79e-05	0.00128	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Prednisone—multiple sclerosis	9.77e-05	0.00128	CcSEcCtD
Ethinyl Estradiol—Angioedema—Methylprednisolone—multiple sclerosis	9.76e-05	0.00128	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Prednisone—multiple sclerosis	9.72e-05	0.00127	CcSEcCtD
Ethinyl Estradiol—Malaise—Triamcinolone—multiple sclerosis	9.66e-05	0.00126	CcSEcCtD
Ethinyl Estradiol—Malaise—Methylprednisolone—multiple sclerosis	9.64e-05	0.00126	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Prednisone—multiple sclerosis	9.55e-05	0.00125	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Mitoxantrone—multiple sclerosis	9.55e-05	0.00125	CcSEcCtD
Ethinyl Estradiol—Oedema—Prednisolone—multiple sclerosis	9.5e-05	0.00124	CcSEcCtD
Ethinyl Estradiol—Dysuria—Methotrexate—multiple sclerosis	9.49e-05	0.00124	CcSEcCtD
Ethinyl Estradiol—Dizziness—Azathioprine—multiple sclerosis	9.48e-05	0.00124	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	9.47e-05	0.00124	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Methotrexate—multiple sclerosis	9.43e-05	0.00123	CcSEcCtD
Ethinyl Estradiol—Cough—Triamcinolone—multiple sclerosis	9.34e-05	0.00122	CcSEcCtD
Ethinyl Estradiol—Urticaria—Mitoxantrone—multiple sclerosis	9.2e-05	0.0012	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Mitoxantrone—multiple sclerosis	9.16e-05	0.0012	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Mitoxantrone—multiple sclerosis	9.16e-05	0.0012	CcSEcCtD
Ethinyl Estradiol—Vomiting—Azathioprine—multiple sclerosis	9.11e-05	0.00119	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Prednisone—multiple sclerosis	9.08e-05	0.00119	CcSEcCtD
Ethinyl Estradiol—Anxiety—Methylprednisolone—multiple sclerosis	9.07e-05	0.00119	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Methotrexate—multiple sclerosis	9.05e-05	0.00118	CcSEcCtD
Ethinyl Estradiol—Infestation—Methotrexate—multiple sclerosis	9.05e-05	0.00118	CcSEcCtD
Ethinyl Estradiol—Rash—Azathioprine—multiple sclerosis	9.04e-05	0.00118	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	9.03e-05	0.00118	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Azathioprine—multiple sclerosis	9.03e-05	0.00118	CcSEcCtD
Ethinyl Estradiol—Depression—Methotrexate—multiple sclerosis	9.02e-05	0.00118	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Dexamethasone—multiple sclerosis	9.02e-05	0.00118	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Betamethasone—multiple sclerosis	9.02e-05	0.00118	CcSEcCtD
Ethinyl Estradiol—Discomfort—Triamcinolone—multiple sclerosis	9.01e-05	0.00118	CcSEcCtD
Ethinyl Estradiol—Discomfort—Methylprednisolone—multiple sclerosis	8.99e-05	0.00118	CcSEcCtD
Ethinyl Estradiol—Headache—Azathioprine—multiple sclerosis	8.98e-05	0.00117	CcSEcCtD
Ethinyl Estradiol—Angioedema—Dexamethasone—multiple sclerosis	8.88e-05	0.00116	CcSEcCtD
Ethinyl Estradiol—Angioedema—Betamethasone—multiple sclerosis	8.88e-05	0.00116	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Prednisone—multiple sclerosis	8.82e-05	0.00115	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Prednisone—multiple sclerosis	8.78e-05	0.00115	CcSEcCtD
Ethinyl Estradiol—Malaise—Betamethasone—multiple sclerosis	8.76e-05	0.00115	CcSEcCtD
Ethinyl Estradiol—Malaise—Dexamethasone—multiple sclerosis	8.76e-05	0.00115	CcSEcCtD
Ethinyl Estradiol—Oedema—Triamcinolone—multiple sclerosis	8.74e-05	0.00114	CcSEcCtD
Ethinyl Estradiol—Infection—Triamcinolone—multiple sclerosis	8.68e-05	0.00114	CcSEcCtD
Ethinyl Estradiol—Infection—Methylprednisolone—multiple sclerosis	8.66e-05	0.00113	CcSEcCtD
Ethinyl Estradiol—Alopecia—Prednisone—multiple sclerosis	8.59e-05	0.00112	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Methylprednisolone—multiple sclerosis	8.55e-05	0.00112	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Mitoxantrone—multiple sclerosis	8.53e-05	0.00112	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Prednisone—multiple sclerosis	8.52e-05	0.00111	CcSEcCtD
Ethinyl Estradiol—Nausea—Azathioprine—multiple sclerosis	8.51e-05	0.00111	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Methylprednisolone—multiple sclerosis	8.47e-05	0.00111	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Prednisone—multiple sclerosis	8.46e-05	0.00111	CcSEcCtD
Ethinyl Estradiol—Asthenia—Mitoxantrone—multiple sclerosis	8.31e-05	0.00109	CcSEcCtD
Ethinyl Estradiol—Anxiety—Betamethasone—multiple sclerosis	8.24e-05	0.00108	CcSEcCtD
Ethinyl Estradiol—Anxiety—Dexamethasone—multiple sclerosis	8.24e-05	0.00108	CcSEcCtD
Ethinyl Estradiol—Discomfort—Dexamethasone—multiple sclerosis	8.17e-05	0.00107	CcSEcCtD
Ethinyl Estradiol—Discomfort—Betamethasone—multiple sclerosis	8.17e-05	0.00107	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Methotrexate—multiple sclerosis	8.17e-05	0.00107	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Methotrexate—multiple sclerosis	8.12e-05	0.00106	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Methotrexate—multiple sclerosis	8.06e-05	0.00105	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Methotrexate—multiple sclerosis	8.02e-05	0.00105	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Methotrexate—multiple sclerosis	7.96e-05	0.00104	CcSEcCtD
Ethinyl Estradiol—Oedema—Dexamethasone—multiple sclerosis	7.93e-05	0.00104	CcSEcCtD
Ethinyl Estradiol—Oedema—Betamethasone—multiple sclerosis	7.93e-05	0.00104	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Mitoxantrone—multiple sclerosis	7.93e-05	0.00104	CcSEcCtD
Ethinyl Estradiol—Infection—Dexamethasone—multiple sclerosis	7.88e-05	0.00103	CcSEcCtD
Ethinyl Estradiol—Infection—Betamethasone—multiple sclerosis	7.88e-05	0.00103	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Prednisone—multiple sclerosis	7.85e-05	0.00103	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Prednisolone—multiple sclerosis	7.83e-05	0.00102	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Methotrexate—multiple sclerosis	7.83e-05	0.00102	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Betamethasone—multiple sclerosis	7.78e-05	0.00102	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Dexamethasone—multiple sclerosis	7.78e-05	0.00102	CcSEcCtD
Ethinyl Estradiol—Angioedema—Prednisone—multiple sclerosis	7.73e-05	0.00101	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Methotrexate—multiple sclerosis	7.68e-05	0.001	CcSEcCtD
Ethinyl Estradiol—Malaise—Prednisone—multiple sclerosis	7.63e-05	0.000998	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Methotrexate—multiple sclerosis	7.59e-05	0.000993	CcSEcCtD
Ethinyl Estradiol—Urticaria—Prednisolone—multiple sclerosis	7.55e-05	0.000987	CcSEcCtD
Ethinyl Estradiol—Fatigue—Triamcinolone—multiple sclerosis	7.54e-05	0.000985	CcSEcCtD
Ethinyl Estradiol—Fatigue—Methylprednisolone—multiple sclerosis	7.52e-05	0.000983	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Methotrexate—multiple sclerosis	7.37e-05	0.000964	CcSEcCtD
Ethinyl Estradiol—Vomiting—Mitoxantrone—multiple sclerosis	7.37e-05	0.000963	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Methotrexate—multiple sclerosis	7.34e-05	0.00096	CcSEcCtD
Ethinyl Estradiol—Rash—Mitoxantrone—multiple sclerosis	7.3e-05	0.000955	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Mitoxantrone—multiple sclerosis	7.3e-05	0.000954	CcSEcCtD
Ethinyl Estradiol—Headache—Mitoxantrone—multiple sclerosis	7.26e-05	0.000949	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Triamcinolone—multiple sclerosis	7.2e-05	0.000942	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Methylprednisolone—multiple sclerosis	7.19e-05	0.00094	CcSEcCtD
Ethinyl Estradiol—Anxiety—Prednisone—multiple sclerosis	7.18e-05	0.000939	CcSEcCtD
Ethinyl Estradiol—Alopecia—Methotrexate—multiple sclerosis	7.18e-05	0.000939	CcSEcCtD
Ethinyl Estradiol—Norethindrone—ALB—multiple sclerosis	7.16e-05	0.022	CrCbGaD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	7.15e-05	0.000936	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	7.13e-05	0.000933	CcSEcCtD
Ethinyl Estradiol—Discomfort—Prednisone—multiple sclerosis	7.12e-05	0.000931	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Methotrexate—multiple sclerosis	7.12e-05	0.000931	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Methotrexate—multiple sclerosis	7.07e-05	0.000925	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Prednisolone—multiple sclerosis	7e-05	0.000916	CcSEcCtD
Ethinyl Estradiol—Urticaria—Triamcinolone—multiple sclerosis	6.94e-05	0.000908	CcSEcCtD
Ethinyl Estradiol—Urticaria—Methylprednisolone—multiple sclerosis	6.93e-05	0.000906	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Triamcinolone—multiple sclerosis	6.91e-05	0.000904	CcSEcCtD
Ethinyl Estradiol—Oedema—Prednisone—multiple sclerosis	6.91e-05	0.000903	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Methylprednisolone—multiple sclerosis	6.89e-05	0.000902	CcSEcCtD
Ethinyl Estradiol—Nausea—Mitoxantrone—multiple sclerosis	6.88e-05	0.0009	CcSEcCtD
Ethinyl Estradiol—Infection—Prednisone—multiple sclerosis	6.86e-05	0.000897	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	6.85e-05	0.000895	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Betamethasone—multiple sclerosis	6.85e-05	0.000895	CcSEcCtD
Ethinyl Estradiol—Back pain—Methotrexate—multiple sclerosis	6.84e-05	0.000895	CcSEcCtD
Ethinyl Estradiol—Fatigue—Betamethasone—multiple sclerosis	6.84e-05	0.000894	CcSEcCtD
Ethinyl Estradiol—Fatigue—Dexamethasone—multiple sclerosis	6.84e-05	0.000894	CcSEcCtD
Ethinyl Estradiol—Methyltestosterone—ALB—multiple sclerosis	6.8e-05	0.0209	CrCbGaD
Ethinyl Estradiol—Nervous system disorder—Prednisone—multiple sclerosis	6.77e-05	0.000886	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Prednisone—multiple sclerosis	6.71e-05	0.000877	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Methotrexate—multiple sclerosis	6.56e-05	0.000858	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Betamethasone—multiple sclerosis	6.53e-05	0.000855	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Dexamethasone—multiple sclerosis	6.53e-05	0.000855	CcSEcCtD
Ethinyl Estradiol—Estrone—ALB—multiple sclerosis	6.49e-05	0.02	CrCbGaD
Ethinyl Estradiol—Gastrointestinal pain—Betamethasone—multiple sclerosis	6.48e-05	0.000848	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Dexamethasone—multiple sclerosis	6.48e-05	0.000848	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Triamcinolone—multiple sclerosis	6.44e-05	0.000842	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Methylprednisolone—multiple sclerosis	6.42e-05	0.00084	CcSEcCtD
Ethinyl Estradiol—Malaise—Methotrexate—multiple sclerosis	6.38e-05	0.000834	CcSEcCtD
Ethinyl Estradiol—Urticaria—Dexamethasone—multiple sclerosis	6.3e-05	0.000824	CcSEcCtD
Ethinyl Estradiol—Urticaria—Betamethasone—multiple sclerosis	6.3e-05	0.000824	CcSEcCtD
Ethinyl Estradiol—Dizziness—Prednisolone—multiple sclerosis	6.28e-05	0.000822	CcSEcCtD
Ethinyl Estradiol—Asthenia—Triamcinolone—multiple sclerosis	6.27e-05	0.00082	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Betamethasone—multiple sclerosis	6.27e-05	0.00082	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Dexamethasone—multiple sclerosis	6.27e-05	0.00082	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Betamethasone—multiple sclerosis	6.27e-05	0.00082	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Dexamethasone—multiple sclerosis	6.27e-05	0.00082	CcSEcCtD
Ethinyl Estradiol—Asthenia—Methylprednisolone—multiple sclerosis	6.26e-05	0.000818	CcSEcCtD
Ethinyl Estradiol—Pruritus—Triamcinolone—multiple sclerosis	6.18e-05	0.000809	CcSEcCtD
Ethinyl Estradiol—Cough—Methotrexate—multiple sclerosis	6.17e-05	0.000807	CcSEcCtD
Ethinyl Estradiol—Pruritus—Methylprednisolone—multiple sclerosis	6.17e-05	0.000807	CcSEcCtD
Ethinyl Estradiol—Rash—Prednisolone—multiple sclerosis	5.99e-05	0.000784	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Prednisolone—multiple sclerosis	5.99e-05	0.000783	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	5.98e-05	0.000782	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Methylprednisolone—multiple sclerosis	5.97e-05	0.00078	CcSEcCtD
Ethinyl Estradiol—Fatigue—Prednisone—multiple sclerosis	5.95e-05	0.000779	CcSEcCtD
Ethinyl Estradiol—Headache—Prednisolone—multiple sclerosis	5.95e-05	0.000779	CcSEcCtD
Ethinyl Estradiol—Discomfort—Methotrexate—multiple sclerosis	5.95e-05	0.000778	CcSEcCtD
Ethinyl Estradiol—Constipation—Prednisone—multiple sclerosis	5.91e-05	0.000772	CcSEcCtD
Ethinyl Estradiol—Dizziness—Triamcinolone—multiple sclerosis	5.78e-05	0.000756	CcSEcCtD
Ethinyl Estradiol—Dizziness—Methylprednisolone—multiple sclerosis	5.77e-05	0.000754	CcSEcCtD
Ethinyl Estradiol—Infection—Methotrexate—multiple sclerosis	5.73e-05	0.00075	CcSEcCtD
Ethinyl Estradiol—SLC10A1—Metabolism—CYP24A1—multiple sclerosis	5.72e-05	0.00172	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	5.71e-05	0.00172	CbGpPWpGaD
Ethinyl Estradiol—Feeling abnormal—Prednisone—multiple sclerosis	5.69e-05	0.000744	CcSEcCtD
Ethinyl Estradiol—Asthenia—Dexamethasone—multiple sclerosis	5.69e-05	0.000744	CcSEcCtD
Ethinyl Estradiol—Asthenia—Betamethasone—multiple sclerosis	5.69e-05	0.000744	CcSEcCtD
Ethinyl Estradiol—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	5.66e-05	0.0017	CbGpPWpGaD
Ethinyl Estradiol—Nervous system disorder—Methotrexate—multiple sclerosis	5.66e-05	0.00074	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Prednisone—multiple sclerosis	5.65e-05	0.000739	CcSEcCtD
Ethinyl Estradiol—Nausea—Prednisolone—multiple sclerosis	5.65e-05	0.000738	CcSEcCtD
Ethinyl Estradiol—ESR2—Generic Transcription Pathway—PGR—multiple sclerosis	5.64e-05	0.0017	CbGpPWpGaD
Ethinyl Estradiol—Pruritus—Dexamethasone—multiple sclerosis	5.61e-05	0.000734	CcSEcCtD
Ethinyl Estradiol—Pruritus—Betamethasone—multiple sclerosis	5.61e-05	0.000734	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Methotrexate—multiple sclerosis	5.61e-05	0.000733	CcSEcCtD
Ethinyl Estradiol—NR1I2—Generic Transcription Pathway—VDR—multiple sclerosis	5.6e-05	0.00169	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.59e-05	0.00168	CbGpPWpGaD
Ethinyl Estradiol—Vomiting—Triamcinolone—multiple sclerosis	5.56e-05	0.000727	CcSEcCtD
Ethinyl Estradiol—Vomiting—Methylprednisolone—multiple sclerosis	5.54e-05	0.000725	CcSEcCtD
Ethinyl Estradiol—Rash—Triamcinolone—multiple sclerosis	5.51e-05	0.000721	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Triamcinolone—multiple sclerosis	5.51e-05	0.00072	CcSEcCtD
Ethinyl Estradiol—Rash—Methylprednisolone—multiple sclerosis	5.5e-05	0.000719	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Methylprednisolone—multiple sclerosis	5.49e-05	0.000718	CcSEcCtD
Ethinyl Estradiol—Urticaria—Prednisone—multiple sclerosis	5.49e-05	0.000718	CcSEcCtD
Ethinyl Estradiol—Headache—Triamcinolone—multiple sclerosis	5.48e-05	0.000716	CcSEcCtD
Ethinyl Estradiol—Headache—Methylprednisolone—multiple sclerosis	5.46e-05	0.000714	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Prednisone—multiple sclerosis	5.46e-05	0.000714	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Prednisone—multiple sclerosis	5.46e-05	0.000714	CcSEcCtD
Ethinyl Estradiol—ABCB1—Allograft Rejection—CD40—multiple sclerosis	5.45e-05	0.00164	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—PABPC1—multiple sclerosis	5.44e-05	0.00164	CbGpPWpGaD
Ethinyl Estradiol—Diarrhoea—Dexamethasone—multiple sclerosis	5.43e-05	0.00071	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Betamethasone—multiple sclerosis	5.43e-05	0.00071	CcSEcCtD
Ethinyl Estradiol—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	5.37e-05	0.00161	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—GPC5—multiple sclerosis	5.37e-05	0.00161	CbGpPWpGaD
Ethinyl Estradiol—ESR1—FOXM1 transcription factor network—MYC—multiple sclerosis	5.34e-05	0.00161	CbGpPWpGaD
Ethinyl Estradiol—ESR1—LKB1 signaling events—MYC—multiple sclerosis	5.24e-05	0.00158	CbGpPWpGaD
Ethinyl Estradiol—Dizziness—Dexamethasone—multiple sclerosis	5.24e-05	0.000686	CcSEcCtD
Ethinyl Estradiol—Dizziness—Betamethasone—multiple sclerosis	5.24e-05	0.000686	CcSEcCtD
Ethinyl Estradiol—ESR1—Regulation of Telomerase—IFNG—multiple sclerosis	5.23e-05	0.00157	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—GPC5—multiple sclerosis	5.23e-05	0.00157	CbGpPWpGaD
Ethinyl Estradiol—Nausea—Triamcinolone—multiple sclerosis	5.19e-05	0.000679	CcSEcCtD
Ethinyl Estradiol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	5.19e-05	0.00156	CbGpPWpGaD
Ethinyl Estradiol—Nausea—Methylprednisolone—multiple sclerosis	5.18e-05	0.000677	CcSEcCtD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—IFNG—multiple sclerosis	5.11e-05	0.00154	CbGpPWpGaD
Ethinyl Estradiol—Hypersensitivity—Prednisone—multiple sclerosis	5.09e-05	0.000665	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	5.08e-05	0.00153	CbGpPWpGaD
Ethinyl Estradiol—Vomiting—Dexamethasone—multiple sclerosis	5.04e-05	0.000659	CcSEcCtD
Ethinyl Estradiol—Vomiting—Betamethasone—multiple sclerosis	5.04e-05	0.000659	CcSEcCtD
Ethinyl Estradiol—Rash—Betamethasone—multiple sclerosis	5e-05	0.000654	CcSEcCtD
Ethinyl Estradiol—Rash—Dexamethasone—multiple sclerosis	5e-05	0.000654	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Betamethasone—multiple sclerosis	5e-05	0.000653	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Dexamethasone—multiple sclerosis	5e-05	0.000653	CcSEcCtD
Ethinyl Estradiol—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.99e-05	0.0015	CbGpPWpGaD
Ethinyl Estradiol—Gastrointestinal disorder—Methotrexate—multiple sclerosis	4.98e-05	0.000652	CcSEcCtD
Ethinyl Estradiol—Fatigue—Methotrexate—multiple sclerosis	4.98e-05	0.000651	CcSEcCtD
Ethinyl Estradiol—ESR1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	4.97e-05	0.00149	CbGpPWpGaD
Ethinyl Estradiol—Headache—Dexamethasone—multiple sclerosis	4.97e-05	0.00065	CcSEcCtD
Ethinyl Estradiol—Headache—Betamethasone—multiple sclerosis	4.97e-05	0.00065	CcSEcCtD
Ethinyl Estradiol—Asthenia—Prednisone—multiple sclerosis	4.95e-05	0.000648	CcSEcCtD
Ethinyl Estradiol—ESR2—Gene Expression—ZFP36L1—multiple sclerosis	4.93e-05	0.00148	CbGpPWpGaD
Ethinyl Estradiol—Estradiol—ALB—multiple sclerosis	4.92e-05	0.0151	CrCbGaD
Ethinyl Estradiol—AOX1—Metabolism—CYP24A1—multiple sclerosis	4.91e-05	0.00148	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—CYP27B1—multiple sclerosis	4.91e-05	0.00148	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	4.91e-05	0.00148	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—RPL5—multiple sclerosis	4.9e-05	0.00147	CbGpPWpGaD
Ethinyl Estradiol—Pruritus—Prednisone—multiple sclerosis	4.89e-05	0.000639	CcSEcCtD
Ethinyl Estradiol—ESR1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	4.86e-05	0.00146	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—SRM—multiple sclerosis	4.78e-05	0.00144	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—CD86—multiple sclerosis	4.77e-05	0.00143	CbGpPWpGaD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	4.76e-05	0.00143	CbGpPWpGaD
Ethinyl Estradiol—Feeling abnormal—Methotrexate—multiple sclerosis	4.76e-05	0.000622	CcSEcCtD
Ethinyl Estradiol—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	4.73e-05	0.00142	CbGpPWpGaD
Ethinyl Estradiol—Diarrhoea—Prednisone—multiple sclerosis	4.73e-05	0.000618	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Methotrexate—multiple sclerosis	4.72e-05	0.000617	CcSEcCtD
Ethinyl Estradiol—Nausea—Betamethasone—multiple sclerosis	4.71e-05	0.000616	CcSEcCtD
Ethinyl Estradiol—Nausea—Dexamethasone—multiple sclerosis	4.71e-05	0.000616	CcSEcCtD
Ethinyl Estradiol—ESR1—Regulation of Telomerase—IL2—multiple sclerosis	4.65e-05	0.0014	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	4.63e-05	0.00139	CbGpPWpGaD
Ethinyl Estradiol—Urticaria—Methotrexate—multiple sclerosis	4.59e-05	0.0006	CcSEcCtD
Ethinyl Estradiol—Dizziness—Prednisone—multiple sclerosis	4.57e-05	0.000597	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Methotrexate—multiple sclerosis	4.56e-05	0.000597	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Methotrexate—multiple sclerosis	4.56e-05	0.000597	CcSEcCtD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—IL2—multiple sclerosis	4.54e-05	0.00137	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—ZNF746—multiple sclerosis	4.54e-05	0.00137	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—GPC5—multiple sclerosis	4.5e-05	0.00135	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.46e-05	0.00134	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	4.42e-05	0.00133	CbGpPWpGaD
Ethinyl Estradiol—Vomiting—Prednisone—multiple sclerosis	4.39e-05	0.000574	CcSEcCtD
Ethinyl Estradiol—Rash—Prednisone—multiple sclerosis	4.35e-05	0.000569	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Prednisone—multiple sclerosis	4.35e-05	0.000569	CcSEcCtD
Ethinyl Estradiol—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	4.34e-05	0.0013	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	4.34e-05	0.0013	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—RRM1—multiple sclerosis	4.33e-05	0.0013	CbGpPWpGaD
Ethinyl Estradiol—Headache—Prednisone—multiple sclerosis	4.33e-05	0.000566	CcSEcCtD
Ethinyl Estradiol—ESR1—Leptin signaling pathway—IL1B—multiple sclerosis	4.31e-05	0.0013	CbGpPWpGaD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—MMP9—multiple sclerosis	4.3e-05	0.00129	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	4.28e-05	0.00129	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	4.28e-05	0.00129	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—CD86—multiple sclerosis	4.26e-05	0.00128	CbGpPWpGaD
Ethinyl Estradiol—Hypersensitivity—Methotrexate—multiple sclerosis	4.25e-05	0.000556	CcSEcCtD
Ethinyl Estradiol—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.22e-05	0.00127	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	4.17e-05	0.00126	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—IL10—multiple sclerosis	4.17e-05	0.00126	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—PTBP1—multiple sclerosis	4.15e-05	0.00125	CbGpPWpGaD
Ethinyl Estradiol—Asthenia—Methotrexate—multiple sclerosis	4.14e-05	0.000542	CcSEcCtD
Ethinyl Estradiol—Nausea—Prednisone—multiple sclerosis	4.1e-05	0.000536	CcSEcCtD
Ethinyl Estradiol—Pruritus—Methotrexate—multiple sclerosis	4.08e-05	0.000534	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	4.08e-05	0.00123	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—IL4—multiple sclerosis	4.06e-05	0.00122	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.04e-05	0.00122	CbGpPWpGaD
Ethinyl Estradiol—ESR1—ATF-2 transcription factor network—MAPK1—multiple sclerosis	3.98e-05	0.0012	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	3.97e-05	0.00119	CbGpPWpGaD
Ethinyl Estradiol—Diarrhoea—Methotrexate—multiple sclerosis	3.95e-05	0.000516	CcSEcCtD
Ethinyl Estradiol—ESR2—Generic Transcription Pathway—VDR—multiple sclerosis	3.94e-05	0.00119	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—PGR—multiple sclerosis	3.86e-05	0.00116	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—PABPC1—multiple sclerosis	3.83e-05	0.00115	CbGpPWpGaD
Ethinyl Estradiol—Dizziness—Methotrexate—multiple sclerosis	3.82e-05	0.000499	CcSEcCtD
Ethinyl Estradiol—ESR1—Validated nuclear estrogen receptor alpha network—MYC—multiple sclerosis	3.82e-05	0.00115	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—FAS—multiple sclerosis	3.74e-05	0.00113	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—RRM1—multiple sclerosis	3.72e-05	0.00112	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	3.72e-05	0.00112	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	3.68e-05	0.00111	CbGpPWpGaD
Ethinyl Estradiol—Vomiting—Methotrexate—multiple sclerosis	3.67e-05	0.00048	CcSEcCtD
Ethinyl Estradiol—Rash—Methotrexate—multiple sclerosis	3.64e-05	0.000476	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Methotrexate—multiple sclerosis	3.64e-05	0.000476	CcSEcCtD
Ethinyl Estradiol—ESR1—Regulation of Telomerase—MYC—multiple sclerosis	3.63e-05	0.00109	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Regulation of Telomerase—TGFB1—multiple sclerosis	3.63e-05	0.00109	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Leptin signaling pathway—STAT3—multiple sclerosis	3.62e-05	0.00109	CbGpPWpGaD
Ethinyl Estradiol—Headache—Methotrexate—multiple sclerosis	3.62e-05	0.000473	CcSEcCtD
Ethinyl Estradiol—ESR1—Regulation of Telomerase—MAPK1—multiple sclerosis	3.56e-05	0.00107	CbGpPWpGaD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—MYC—multiple sclerosis	3.55e-05	0.00107	CbGpPWpGaD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—TGFB1—multiple sclerosis	3.54e-05	0.00107	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.52e-05	0.00106	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	3.49e-05	0.00105	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—RPL5—multiple sclerosis	3.49e-05	0.00105	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—CD80—multiple sclerosis	3.48e-05	0.00105	CbGpPWpGaD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	3.46e-05	0.00104	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—RPL5—multiple sclerosis	3.45e-05	0.00104	CbGpPWpGaD
Ethinyl Estradiol—Nausea—Methotrexate—multiple sclerosis	3.43e-05	0.000448	CcSEcCtD
Ethinyl Estradiol—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.42e-05	0.00103	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—CYP27B1—multiple sclerosis	3.37e-05	0.00101	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—CYP24A1—multiple sclerosis	3.37e-05	0.00101	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	3.36e-05	0.00101	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.36e-05	0.00101	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—SLC11A1—multiple sclerosis	3.34e-05	0.00101	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.29e-05	0.00099	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Leptin signaling pathway—MAPK1—multiple sclerosis	3.29e-05	0.000989	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	3.16e-05	0.00095	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	3.16e-05	0.000949	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—HNRNPA1—multiple sclerosis	3.15e-05	0.000947	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—U2AF2—multiple sclerosis	3.15e-05	0.000947	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	3.15e-05	0.000947	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.11e-05	0.000937	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—CD80—multiple sclerosis	3.11e-05	0.000934	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.1e-05	0.000933	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.1e-05	0.000933	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	3.09e-05	0.000928	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—GPC5—multiple sclerosis	3.08e-05	0.000927	CbGpPWpGaD
Ethinyl Estradiol—ESR1—ATF-2 transcription factor network—IL6—multiple sclerosis	3.06e-05	0.000921	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.94e-05	0.000884	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—TYK2—multiple sclerosis	2.94e-05	0.000883	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.89e-05	0.000868	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Generic Transcription Pathway—PGR—multiple sclerosis	2.85e-05	0.000856	CbGpPWpGaD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	2.79e-05	0.000839	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.76e-05	0.000832	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—PGR—multiple sclerosis	2.72e-05	0.000817	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—VDR—multiple sclerosis	2.7e-05	0.000811	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	2.69e-05	0.000808	CbGpPWpGaD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—IL6—multiple sclerosis	2.67e-05	0.000803	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—CD28—multiple sclerosis	2.67e-05	0.000803	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.63e-05	0.000792	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—RRM1—multiple sclerosis	2.55e-05	0.000768	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	2.5e-05	0.000752	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—ZFP36L1—multiple sclerosis	2.49e-05	0.000748	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—BCHE—multiple sclerosis	2.49e-05	0.000748	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	2.45e-05	0.000738	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—LINGO1—multiple sclerosis	2.36e-05	0.00071	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—SRM—multiple sclerosis	2.32e-05	0.000697	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.27e-05	0.000681	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Generic Transcription Pathway—MYC—multiple sclerosis	2.23e-05	0.00067	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	2.21e-05	0.000666	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	2.19e-05	0.000659	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—IL2—multiple sclerosis	2.18e-05	0.000656	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.16e-05	0.000649	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Biological oxidations—POMC—multiple sclerosis	2.15e-05	0.000646	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—BCHE—multiple sclerosis	2.14e-05	0.000643	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.1e-05	0.00063	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TAGAP—multiple sclerosis	2.05e-05	0.000615	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Generic Transcription Pathway—VDR—multiple sclerosis	1.99e-05	0.000598	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.98e-05	0.000596	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—SRM—multiple sclerosis	1.96e-05	0.00059	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—PABPC1—multiple sclerosis	1.93e-05	0.00058	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	1.92e-05	0.000577	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—CD86—multiple sclerosis	1.9e-05	0.000573	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—VDR—multiple sclerosis	1.9e-05	0.000571	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	1.88e-05	0.000565	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—MAPK1—multiple sclerosis	1.87e-05	0.000562	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.85e-05	0.000555	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.84e-05	0.000552	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Biological oxidations—POMC—multiple sclerosis	1.82e-05	0.000547	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—S1PR1—multiple sclerosis	1.79e-05	0.000538	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—RPL5—multiple sclerosis	1.74e-05	0.000523	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—GPC5—multiple sclerosis	1.74e-05	0.000523	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—SRM—multiple sclerosis	1.71e-05	0.000514	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	1.7e-05	0.000512	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.7e-05	0.000512	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—CCR5—multiple sclerosis	1.69e-05	0.000508	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.66e-05	0.000498	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—HLA-A—multiple sclerosis	1.65e-05	0.000495	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	1.63e-05	0.000491	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	1.63e-05	0.000491	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.59e-05	0.000479	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—TNF—multiple sclerosis	1.59e-05	0.000478	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.59e-05	0.000477	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Generic Transcription Pathway—MYC—multiple sclerosis	1.57e-05	0.000471	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.56e-05	0.000468	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.55e-05	0.000467	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—APOE—multiple sclerosis	1.54e-05	0.000462	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—RGS1—multiple sclerosis	1.52e-05	0.000457	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—APOE—multiple sclerosis	1.5e-05	0.00045	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GPC5—multiple sclerosis	1.49e-05	0.000449	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.48e-05	0.000446	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—BCHE—multiple sclerosis	1.47e-05	0.000441	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.46e-05	0.00044	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—GPR65—multiple sclerosis	1.44e-05	0.000434	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—IL6—multiple sclerosis	1.44e-05	0.000432	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—CD80—multiple sclerosis	1.39e-05	0.000418	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	1.38e-05	0.000416	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	1.38e-05	0.000416	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—PGR—multiple sclerosis	1.37e-05	0.000412	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.35e-05	0.000406	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CXCL13—multiple sclerosis	1.32e-05	0.000397	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CCR1—multiple sclerosis	1.32e-05	0.000397	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—APOE—multiple sclerosis	1.29e-05	0.000387	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—POMC—multiple sclerosis	1.29e-05	0.000387	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GPC5—multiple sclerosis	1.26e-05	0.00038	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—RRM1—multiple sclerosis	1.24e-05	0.000372	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.2e-05	0.000362	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.2e-05	0.000362	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—TYK2—multiple sclerosis	1.17e-05	0.000353	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—ALB—multiple sclerosis	1.17e-05	0.000353	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.12e-05	0.000337	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—POMC—multiple sclerosis	1.11e-05	0.000333	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GPC5—multiple sclerosis	1.1e-05	0.000331	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—MYC—multiple sclerosis	1.07e-05	0.000323	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—CD4—multiple sclerosis	1.06e-05	0.000319	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—SRM—multiple sclerosis	1.05e-05	0.000317	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.05e-05	0.000315	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—ALB—multiple sclerosis	1.01e-05	0.000303	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Biological oxidations—POMC—multiple sclerosis	9.76e-06	0.000293	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—VDR—multiple sclerosis	9.57e-06	0.000288	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CCL3—multiple sclerosis	9.4e-06	0.000283	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—RRM1—multiple sclerosis	9.12e-06	0.000274	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PTGER4—multiple sclerosis	9.05e-06	0.000272	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PGR—multiple sclerosis	8.91e-06	0.000268	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—APOE—multiple sclerosis	8.82e-06	0.000265	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CXCR3—multiple sclerosis	8.74e-06	0.000263	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CD28—multiple sclerosis	8.65e-06	0.00026	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CCR2—multiple sclerosis	8.5e-06	0.000256	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	8.42e-06	0.000253	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	8.4e-06	0.000253	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	8.23e-06	0.000248	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—STAT3—multiple sclerosis	8.21e-06	0.000247	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.12e-06	0.000244	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Generic Transcription Pathway—MYC—multiple sclerosis	7.9e-06	0.000238	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CNR1—multiple sclerosis	7.84e-06	0.000236	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	7.84e-06	0.000236	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—MYC—multiple sclerosis	7.63e-06	0.00023	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—TGFB1—multiple sclerosis	7.61e-06	0.000229	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—POMC—multiple sclerosis	7.58e-06	0.000228	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—MYC—multiple sclerosis	7.55e-06	0.000227	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—MAPK1—multiple sclerosis	7.47e-06	0.000225	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	7.42e-06	0.000223	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	7.42e-06	0.000223	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—BCHE—multiple sclerosis	7.1e-06	0.000214	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CXCL10—multiple sclerosis	7.06e-06	0.000212	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.98e-06	0.00021	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—ALB—multiple sclerosis	6.91e-06	0.000208	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GPC5—multiple sclerosis	6.78e-06	0.000204	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.36e-06	0.000191	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CD86—multiple sclerosis	6.17e-06	0.000186	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CCL5—multiple sclerosis	6.08e-06	0.000183	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—BCHE—multiple sclerosis	6.01e-06	0.000181	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—IL6—multiple sclerosis	5.74e-06	0.000173	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—SPP1—multiple sclerosis	5.63e-06	0.000169	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—RRM1—multiple sclerosis	5.62e-06	0.000169	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CCR5—multiple sclerosis	5.48e-06	0.000165	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—IL2RA—multiple sclerosis	5.4e-06	0.000162	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.27e-06	0.000159	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—BCHE—multiple sclerosis	5.24e-06	0.000158	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—APOE—multiple sclerosis	4.98e-06	0.00015	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CD80—multiple sclerosis	4.5e-06	0.000135	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—POMC—multiple sclerosis	4.28e-06	0.000129	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—APOE—multiple sclerosis	4.27e-06	0.000129	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CCL2—multiple sclerosis	4.19e-06	0.000126	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—MYC—multiple sclerosis	3.81e-06	0.000114	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TYK2—multiple sclerosis	3.8e-06	0.000114	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—POMC—multiple sclerosis	3.67e-06	0.00011	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—APOE—multiple sclerosis	3.62e-06	0.000109	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ALB—multiple sclerosis	3.35e-06	0.000101	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—BCHE—multiple sclerosis	3.23e-06	9.71e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—IL2—multiple sclerosis	3.16e-06	9.52e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—APOE—multiple sclerosis	3.15e-06	9.48e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—POMC—multiple sclerosis	3.11e-06	9.35e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MMP9—multiple sclerosis	2.99e-06	9.01e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ALB—multiple sclerosis	2.83e-06	8.52e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—POMC—multiple sclerosis	2.71e-06	8.14e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—STAT3—multiple sclerosis	2.66e-06	8.01e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MYC—multiple sclerosis	2.47e-06	7.44e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—ALB—multiple sclerosis	2.47e-06	7.43e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TGFB1—multiple sclerosis	2.47e-06	7.42e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MAPK1—multiple sclerosis	2.42e-06	7.28e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—APOE—multiple sclerosis	1.94e-06	5.84e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—IL6—multiple sclerosis	1.86e-06	5.59e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—POMC—multiple sclerosis	1.67e-06	5.02e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ALB—multiple sclerosis	1.52e-06	4.57e-05	CbGpPWpGaD
